MIR1260A, a microRNA, has been identified as a significant biomarker in the context of female infertility, as its significance emerged when cases of male infertility were excluded from the study [PMC9580729]. This suggests that MIR1260A may be associated with female reproductive pathologies or could serve as an indicator of such conditions [PMC9580729]. Further research has narrowed down the gene targets of MIR1260A to 42 significant genes through a comparison between TargetScan and miRTarBase databases [PMC8504092]. These gene targets have been shown to interact significantly at the protein level according to String database analysis [PMC8504092]. Additionally, MIR1260A has been proposed as a potential prognostic biomarker due to its differential expression in peripheral blood [PMC8504092]. Its expression levels have also been observed in serum and FFPE tissues of prostate cancer patients, indicating its potential relevance in oncology [PMC8504092]. Interestingly, while MIR1260A expression levels varied among patients with prostate cancer who did not receive chemotherapy—increasing in 50% and decreasing in another 50%—it was consistently downregulated on day 7 compared to baseline levels on day 1 across different control and irradiated groups [PMC8504092; PMC7169272]..
-- -cca u A ACC - A Aaaaca accuuu gc c UCCC UCUG CC CC c |||||| || | |||| |||| || || uggaaa cg g aggg agac gg gg u aa aaac u - --- u - cgcuac
Disease | Description | Category | PubMed ID |
---|
Accession | MIMAT0005911 |
Description | Homo sapiens hsa-miR-1260a mature miRNA |
Sequence | 14 - AUCCCACCUCUGCCACCA - 31 |
Evidence |
experimental
Illumina [1] |
Database links |
![]() ![]() ![]() |
Predicted targets |
![]() ![]() ![]() |
|